This inventor holds 5 USPTO granted patents, plus 1 CIPO patent. Top assignees: Novartis Vaccines & Diagnostics, Gmbh, Novartis Ag. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Orinda, CA (US) (2012 - 2013)
- Emeryville, CA (US) (2012 - 2014)
Company Filing History:
Years Active: 2012-2014
Title: The Innovative Contributions of Victoria A. Sharma in HIV Research
Introduction
Victoria A. Sharma, an accomplished inventor based in Emeryville, California, has made significant strides in the field of biomedical research, particularly related to HIV. With an impressive portfolio of five patents, her work focuses on developing innovative methods for generating immune responses against the HIV virus, showcasing her dedication to advancing medical science.
Latest Patents
Sharma’s latest patents include groundbreaking methods of utilizing fusion proteins to generate immune responses in subjects. One noteworthy patent describes a method of generating an immune response using fusion proteins consisting of CD4 minimal modules and HIV Tat scaffold polypeptides, which bind to the HIV envelope. This process exposes cryptic neutralization epitopes, facilitating better identification and treatment options for HIV. Additionally, another patent outlines a method for generating immune responses through nucleic acids encoding fusion proteins that interact with HIV envelope polypeptides, also aimed at improving therapeutic approaches to HIV treatment.
Career Highlights
Throughout her career, Victoria A. Sharma has been associated with reputable organizations including Novartis Vaccines & Diagnostics and Novartis AG. Her tenure at these companies has allowed her to develop and refine her innovative ideas in a collaborative and resource-rich environment, further underscoring her expertise and commitment to HIV research.
Collaborations
Working alongside esteemed colleagues such as Indresh K. Srivastava and Susan Barnett, Sharma has benefited from collaborative efforts that enhance the development of her patented technologies. This teamwork has proven instrumental in advancing research and bringing new therapeutic possibilities to light.
Conclusion
In conclusion, Victoria A. Sharma stands out as a leading inventor whose contributions to HIV research pave the way for future innovation. Her patents reflect a deep understanding of immunology and a commitment to fighting the HIV virus. As she continues to develop her research, Sharma's work promises to have a lasting impact on public health and disease prevention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile